PDL BioPharma, Inc. Stock Option Agreement Amendment Acknowledgment
Contract Categories:
Business Finance
›
Stock Agreements
Summary
This agreement is between PDL BioPharma, Inc. and a participant who has received stock option grants. It acknowledges that the company has amended the terms of its Stock Option Agreement as of November 15, 2019, and that these new terms now apply to the participant’s existing stock option grants. By signing, the participant agrees to be bound by the amended agreement for all relevant stock options. The document also references the company’s 2018 Amended Restated 2005 Equity Incentive Plan.
EX-10.71 8 pdli1231201910-kex1071.htm FORM OF STOCK OPTION AGREEMENT AMENDMENT ACKNOWLEDGEMENT Exhibit
Exhibit 10.71
PDL BioPharma, Inc.
Stock Option Agreement Amendment Acknowledgment
The Board of PDL BioPharma, Inc., has on November 15, 2019, amended the Stock Option Agreement applicable to the attached Stock Option Grant Notice(s) (inclusive of the Amended Stock Option Grant Notice(s) corresponding thereto)(the “Notices”), with the intent that amended the amended Stock Option Agreement shall be applicable thereto. The Participant acknowledges, agrees and accepts the amended Stock Option Agreement as governing the awards represented in the attached Notice(s):
Stock Option Grant Notice(s) of [ ].
In addition, attached is the 2018 Amended Restated 2005 Equity Incentive Plan “plan”.
PDL BIOPHARMA, INC. | PARTICIPANT | |||
By: | By: | |||
Print Name: | Print Name: | |||
Title: | ||||
Date: | Date: | |||
